Profound Medical Corp. (PROF)
USD 5.37
(-2.81%)
USD 5.37
(-2.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -28.61 Million USD | 1.56% |
| 2022 | -29.6 Million USD | 2.27% |
| 2021 | -30.29 Million USD | -60.58% |
| 2020 | -18.86 Million USD | -24.65% |
| 2019 | -15.13 Million CAD | -2.07% |
| 2018 | -14.82 Million CAD | 15.88% |
| 2017 | -17.62 Million CAD | -12.7% |
| 2016 | -15.64 Million CAD | -39.36% |
| 2015 | -11.22 Million CAD | -158.67% |
| 2014 | -4.33 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.83 Million USD | 204.69% |
| 2024 Q1 | -7.44 Million USD | 14.8% |
| 2023 Q1 | -6.83 Million USD | -8.57% |
| 2023 FY | -29.14 Million USD | 1.56% |
| 2023 Q4 | -9.02 Million USD | -37.57% |
| 2023 Q3 | -6.56 Million USD | -201.93% |
| 2023 Q2 | 6.43 Million USD | 194.12% |
| 2022 Q1 | 7.29 Million USD | 174.96% |
| 2022 Q3 | -8.23 Million USD | -5.86% |
| 2022 Q4 | -6.29 Million USD | 23.51% |
| 2022 Q2 | -7.77 Million USD | -206.66% |
| 2022 FY | -29.6 Million USD | 2.27% |
| 2021 FY | -30.29 Million USD | -60.58% |
| 2021 Q1 | -6.57 Million USD | 80.06% |
| 2021 Q3 | -7.6 Million USD | -19.16% |
| 2021 Q4 | -9.72 Million USD | -27.88% |
| 2021 Q2 | -6.38 Million USD | 2.86% |
| 2020 Q1 | 4.62 Million CAD | 8.24% |
| 2020 Q3 | 5.11 Million CAD | 28.03% |
| 2020 Q4 | -32.95 Million USD | -743.99% |
| 2020 FY | -18.86 Million USD | -24.65% |
| 2020 Q2 | 3.99 Million CAD | -13.49% |
| 2019 Q1 | -1.93 Million CAD | 30.66% |
| 2019 Q4 | 4.26 Million CAD | -6.84% |
| 2019 Q3 | 4.58 Million CAD | 207.46% |
| 2019 Q2 | -4.26 Million CAD | -120.81% |
| 2019 FY | -15.13 Million CAD | -2.07% |
| 2018 Q3 | -3.88 Million CAD | 6.96% |
| 2018 Q1 | -3.54 Million CAD | 18.02% |
| 2018 FY | -14.82 Million CAD | 15.88% |
| 2018 Q4 | -2.78 Million CAD | 28.36% |
| 2018 Q2 | -4.17 Million CAD | -17.72% |
| 2017 Q3 | -4.86 Million CAD | -72.08% |
| 2017 FY | -17.62 Million CAD | -12.7% |
| 2017 Q4 | -4.32 Million CAD | 11.09% |
| 2017 Q2 | -2.82 Million CAD | 26.92% |
| 2017 Q1 | -3.87 Million CAD | 19.82% |
| 2016 Q1 | -3.6 Million CAD | -41.33% |
| 2016 Q3 | -3.77 Million CAD | -10.2% |
| 2016 Q4 | -4.82 Million CAD | -27.74% |
| 2016 FY | -15.64 Million CAD | -39.36% |
| 2016 Q2 | -3.42 Million CAD | 4.8% |
| 2015 Q2 | -4.49 Million CAD | -8475.12% |
| 2015 Q1 | -52.46 Thousand CAD | 72.17% |
| 2015 Q4 | -2.54 Million CAD | 7.55% |
| 2015 FY | -11.22 Million CAD | -158.67% |
| 2015 Q3 | -2.75 Million CAD | 38.7% |
| 2014 Q1 | -814.83 Thousand CAD | 0.0% |
| 2014 Q4 | -188.47 Thousand CAD | 44.29% |
| 2014 FY | -4.33 Million CAD | 0.0% |
| 2014 Q3 | -338.3 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -99.262% |
| Cerus Corporation | -30.05 Million USD | 4.782% |
| OrthoPediatrics Corp. | -25.76 Million USD | -11.061% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -169.42% |
| Talis Biomedical Corporation | -66.81 Million USD | 57.171% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -65.449% |
| Inogen, Inc. | -109.38 Million USD | 73.839% |
| Spectral AI, Inc. | -12.98 Million USD | -120.394% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 54.28% |
| CVRx, Inc. | -43.1 Million USD | 33.61% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -711.111% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -130.254% |
| Orthofix Medical Inc. | -139.11 Million USD | 79.429% |
| Venus Concept Inc. | -28.3 Million USD | -1.084% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 47.035% |
| Bioventus Inc. | -81.72 Million USD | 64.985% |
| BrainsWay Ltd. | -4.92 Million USD | -480.8% |
| Envoy Medical, Inc. | -18.37 Million USD | -55.767% |
| electroCore, Inc. | -18.8 Million USD | -52.172% |
| IceCure Medical Ltd | -15.57 Million USD | -83.719% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 40.976% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -65.717% |
| MaxCyte, Inc. | -48.29 Million USD | 40.752% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -139.359% |
| Nexalin Technology, Inc. | -5.69 Million USD | -402.362% |
| PAVmed Inc | -68.79 Million USD | 58.404% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 49.409% |
| RxSight, Inc. | -50.08 Million USD | 42.865% |
| Sight Sciences, Inc. | -57.27 Million USD | 50.037% |
| SI-BONE, Inc. | -46.93 Million USD | 39.025% |
| TELA Bio, Inc. | -44.07 Million USD | 35.074% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 47.154% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 44.357% |
| LivaNova PLC | -68.49 Million USD | 58.224% |
| 908 Devices Inc. | -42.75 Million USD | 33.075% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 83.497% |
| Nemaura Medical Inc. | -9.59 Million USD | -198.231% |
| NeuroPace, Inc. | -27.17 Million USD | -5.307% |
| LENSAR, Inc. | -12.22 Million USD | -134.001% |
| Apyx Medical Corporation | -17.25 Million USD | -65.803% |
| Cutera, Inc. | -156.23 Million USD | 81.683% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -232.589% |
| BioSig Technologies, Inc. | -28.51 Million USD | -0.365% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 67.348% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -27.488% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 125.659% |
| Axonics, Inc. | -26.05 Million USD | -9.821% |
| Outset Medical, Inc. | -169.77 Million USD | 83.144% |
| IRIDEX Corporation | -10 Million USD | -185.96% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 73.788% |
| IRadimed Corporation | 20.03 Million USD | 242.827% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -247.071% |
| INVO Bioscience, Inc. | -6.76 Million USD | -322.866% |
| Telesis Bio, Inc. | -35.15 Million USD | 18.589% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 299.693% |
| Varex Imaging Corporation | 32.1 Million USD | 189.146% |
| Quipt Home Medical Corp. | 3.91 Million USD | 830.186% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -135.853% |
| Pulmonx Corporation | -61.93 Million USD | 53.797% |
| Dynatronics Corporation | -2.27 Million USD | -1158.926% |
| Modular Medical, Inc. | -17.52 Million USD | -63.249% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -95.478% |
| Semler Scientific, Inc. | 22.25 Million USD | 228.577% |
| InMode Ltd. | 195.66 Million USD | 114.625% |
| Bruker Corporation | 436.9 Million USD | 106.55% |
| Cytosorbents Corporation | -31.2 Million USD | 8.309% |
| DexCom, Inc. | 597.7 Million USD | 104.788% |
| Align Technology, Inc. | 643.33 Million USD | 104.448% |
| Viveve Medical, Inc. | -21.55 Million USD | -32.77% |
| ZimVie Inc. | -30.93 Million USD | 7.508% |
| Movano Inc. | -29.69 Million USD | 3.617% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -2.769% |
| Nexalin Technology, Inc. | -5.69 Million USD | -402.362% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -711.111% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 87.731% |
| Insulet Corporation | 220 Million USD | 113.007% |
| enVVeno Medical Corporation | -25.23 Million USD | -13.385% |
| Surmodics, Inc. | -5.64 Million USD | -406.926% |
| iCAD, Inc. | -7.68 Million USD | -272.168% |
| Nuwellis, Inc. | -17.63 Million USD | -62.314% |
| Biotricity, Inc. | -8.82 Million USD | -224.141% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 77.137% |
| Aethlon Medical, Inc. | -12.63 Million USD | -126.454% |
| InspireMD, Inc. | -21.14 Million USD | -35.345% |
| PAVmed Inc. | -68.79 Million USD | 58.404% |
| BIOLASE, Inc. | -17.93 Million USD | -59.536% |
| Beyond Air, Inc. | -63 Million USD | 54.582% |
| FONAR Corporation | 16.53 Million USD | 273.059% |
| AxoGen, Inc. | -21.46 Million USD | -33.333% |
| Vivani Medical, Inc. | -26.96 Million USD | -6.123% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 258.616% |
| Inari Medical, Inc. | -14.03 Million USD | -103.934% |
| UFP Technologies, Inc. | 57.66 Million USD | 149.625% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -480.729% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -353.807% |
| Tenon Medical, Inc. | -15.72 Million USD | -81.955% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -282.874% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 32.993% |
| AdaptHealth Corp. | -598.4 Million USD | 95.218% |
| Sintx Technologies, Inc. | -13.35 Million USD | -114.224% |
| NanoVibronix, Inc. | -3.43 Million USD | -732.829% |
| Quanterix Corporation | -49.7 Million USD | 42.424% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -135.853% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -7391.099% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 91.444% |
| TransMedics Group, Inc. | -28.72 Million USD | 0.386% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -21.193% |
| NeuroMetrix, Inc. | -7.15 Million USD | -300.139% |
| Hyperfine, Inc. | -48.11 Million USD | 40.526% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 55.993% |
| Biomerica, Inc. | -6.36 Million USD | -349.442% |
| Bone Biologics Corporation | -9.42 Million USD | -203.512% |
| AVITA Medical, Inc. | -40.4 Million USD | 29.172% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -177.523% |
| Silk Road Medical, Inc | -59.27 Million USD | 51.72% |